BetterLife Pharma Inc
Canadian Securities Exchange:BETRView on OTCQB

  • LAST PRICE
    0.1050
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.1050/ 18
  • Ask / Lots
    0.1250/ 138
  • Open / Previous Close
    --- / 0.1050
  • Day Range
    ---
  • 52 Week Range
    0.0500
    0.1950
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Today

      Show headlines and story abstract

    • 6 hours ago by Dow Jones
      Companies Mentioned: BETR

      BetterLife Obtains Favourable Cardiac Safety Data for BETR-001

      VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic derivative of lysergic acid diethylamide ("LSD"), announced it has completed one of its IND-enabling cardiac safety studies of BETR-001. These GLP in vitro studies demonstrated that BETR-001 has minimal impact on the human ether-a-go-go-related gene (hERG) channel, an important ion channel for cardiac functioning.

Peers Headlines